Richard Pzena Halozyme Therapeutics, Inc. Transaction History

Pzena Investment Management LLC

  • $30.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$32.86 - $55.7 $173,862 - $294,708
-5,291 Reduced 36.47%
9,216 $351,000
Q4 2022

Feb 03, 2023
BUY
$40.06 - $59.44 $581,150 - $862,296
14,507 New
14,507 $825,000
Q2 2022

Aug 05, 2022
SELL
$37.35 - $48.3 $587,814 - $760,145
-15,738 Closed
0 $0
Q1 2022

May 06, 2022
BUY
$31.97 - $41.06 $503,143 - $646,202
15,738 New
15,738 $628,000

Others Institutions Holding HALO

# of Institutions
543
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track Richard Pzena's Portfolio

Track Richard Pzena Portfolio

Follow Richard Pzena (Pzena Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email